KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Revenue (2017 - 2025)

Moderna (MRNA) has disclosed Revenue for 9 consecutive years, with $678.0 million as the latest value for Q4 2025.

  • Quarterly Revenue fell 29.81% to $678.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 billion through Dec 2025, down 38.69% year-over-year, with the annual reading at $1.9 billion for FY2025, 39.93% down from the prior year.
  • Revenue for Q4 2025 was $678.0 million at Moderna, down from $1.0 billion in the prior quarter.
  • The five-year high for Revenue was $7.2 billion in Q4 2021, with the low at $108.0 million in Q1 2025.
  • Average Revenue over 5 years is $2.5 billion, with a median of $1.9 billion recorded in 2023.
  • The sharpest move saw Revenue soared 24112.5% in 2021, then crashed 92.76% in 2023.
  • Over 5 years, Revenue stood at $7.2 billion in 2021, then decreased by 29.5% to $5.1 billion in 2022, then tumbled by 44.71% to $2.8 billion in 2023, then tumbled by 65.64% to $966.0 million in 2024, then dropped by 29.81% to $678.0 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $678.0 million, $1.0 billion, and $142.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.